Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.

Taichi Isobe; Keita Uchino; Chinatsu Makiyama; Hiroshi Ariyama; Shuji Arita; Shingo Tamura; Masato Komoda; Hitoshi Kusaba; Tsuyoshi Shirakawa; Taito Esaki; Kenji Mitsugi; Shigeo Takaishi; Koichi Akashi; Eishi Baba

首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.

【24h】

Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.

机译：日本转移性结直肠癌转移性结直肠癌的不良事件分析。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Pre-existing hypertension appears to be a risk factor for BV-related deterioration of hypertension.

机译：预先存在的高血压似乎是高血压与BV相关恶化的危险因素。

著录项

来源
《Anticancer Research: International Journal of Cancer Research and Treatment》 |2014年第4期|共6页
作者
Taichi Isobe; Keita Uchino; Chinatsu Makiyama; Hiroshi Ariyama; Shuji Arita; Shingo Tamura; Masato Komoda; Hitoshi Kusaba; Tsuyoshi Shirakawa; Taito Esaki; Kenji Mitsugi; Shigeo Takaishi; Koichi Akashi; Eishi Baba;
展开▼
作者单位

Department of Comprehensive Clinical Oncology Faculty of Medical Sciences Kyushu University 3-1;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan. [J] . Taichi Isobe, Keita Uchino, Chinatsu Makiyama, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第4期

机译：日本转移性结直肠癌转移性结直肠癌的不良事件分析。
2. A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial [J] . Shigeyoshi Iwamoto, Akira Ooki, Satoshi Morita, Cancer Medicine . 2018,第9期

机译：一项前瞻性II期研究旨在检查KRAS野生型不可切除转移性结直肠癌患者的生活质量与一线化疗加西妥昔单抗不良事件之间的关系：QUACK试验
3. A prospective observational study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial [J] . OokiA., AndoM., SakamotoJ., Japanese journal of clinical oncology. . 2014,第4期

机译：一项前瞻性观察性研究，以探讨KRAS野生型不可切除转移性结直肠癌患者一线化疗加西妥昔单抗的生活质量与不良事件之间的关系：QUACK试验
4. Colorectal cancer screening: cost-effectiveness and adverse events [C] . D. LIEBERMA Falk Symposium . 2006

机译：结肠直肠癌筛选：成本效益和不良事件
5. Guanylyl Cyclase C Vaccines for Secondary Prevention of Metastatic Colorectal Cancer [D] . Flickinger, John C., Jr. 2023

机译：古达利环酶C疫苗用于转移性结直肠癌的二级预防
6. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports [O] . Apolonia Novillo, María Gaibar, Alicia Romero-Lorca, 2020

机译：含贝伐单抗的化疗在转移性结直肠癌和CXCL5表达中的疗效：六例报告
7. The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer [O] . Seung Tae Kim, Hee Kyung Kim, Jeeyun Lee, 2018

机译：微卫星不稳定性状态和初级肿瘤的外向性对转移结直肠癌患者含贝伐单抗化疗效果的影响

Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.

摘要

著录项

相似文献

相关主题

期刊订阅